SLC27A2 and melanoma: For example, blocking FATP2 in melanoma cells in the aging microenvironment can inhibit their lipid accumulation, and SLC27A2 specific inhibitors can slow down tumor growth, making SLC27A2 a beneficial target for targeted treatment of melanoma cells [30].